Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
        Tocris Bioscience™ Betulinic acid
    
    
    
    
    
    
    
    
    
    
        
                    Click to view available options
                
                
                    
                            
                                Quantity:
                            
                        
                        
                            
                                10 mg
                            
                        
                            
                                50 mg
                            
                        
                    Description
Betulinic acid is a natural triterpenoid that displays anti-HIV and antitumor activity. Induces the production of reactive oxygen species (ROS) and activates NF-κB. Also a GPBA receptor partial agonist (EC50 = 1.04 μM, efficacy 83%). Betulinic acid suppresses areobic glycolysis by regulating the Cav-1/NF-κB/c-Myc pathway in and inhibits growth in breast cancer cells.
                        
                        
                        
                        
                        
                        
                        
                        
                        
                    
                
                
                    
                
                
    
                
    
            Specifications
Specifications
| Quantity | 10 mg | 
| Formula Weight | 456.7 | 
| Purity | >98% | 
| Molecular Weight (g/mol) | 456.711 | 
| Chemical Name or Material | Betulinic acid | 
Safety and Handling
| Recommended Storage | Store at +4°C | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction